These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 5873053)

  • 21. [Symptoms of diabetes mellitus in liver cirrhosis].
    Tóth A; Tornóczky J; Parti G; Tóth G; Pierre B
    Orv Hetil; 1980 Apr; 121(14):819-25. PubMed ID: 7383658
    [No Abstract]   [Full Text] [Related]  

  • 22. [The dobutamine-dopamine combination versus amrinone in congestive heart failure with a marked edematogenic sign complicated by functional kidney failure. A comparison between 2 different models of inotropic stimulation and diuresis potentiation].
    De Vecchis R; Pucciarelli G; Nocerino L; Cocozza M; Setaro A; Torre G; Imperatore F
    Minerva Cardioangiol; 1998 May; 46(5):163-74. PubMed ID: 9842199
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Challenging consults: application of principles of physiology and biochemistry to the bedside. Osmotic diuresis: the importance of counting the number of osmoles excreted.
    Levin A; Klassen J; Halperin ML
    Clin Invest Med; 1995 Oct; 18(5):401-5. PubMed ID: 8529323
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immediate recovery of renal function after orthotopic liver transplantation in a patient with hepatorenal syndrome requiring hemodialysis for more than 8 months.
    Storm C; Bernhardt WM; Schaeffner E; Neuhaus R; Pascher A; Neuhaus P; Hasper D; Frei U; Kahl A
    Transplant Proc; 2007 Mar; 39(2):544-6. PubMed ID: 17362778
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impairment of renal function during moderate physical exercise in cirrhotic patients with ascites: relationship with the activity of neurohormonal systems.
    Saló J; Guevara M; Fernández-Esparrach G; Bataller R; Ginès A; Jimenez W; Ginès P; Rivera F; Arroyo V; Rodés J
    Hepatology; 1997 Jun; 25(6):1338-42. PubMed ID: 9185749
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of novel vasopressin receptor antagonists on renal function and cardiac hypertrophy in rats with experimental congestive heart failure.
    Bishara B; Shiekh H; Karram T; Rubinstein I; Azzam ZS; Abu-Saleh N; Nitecki S; Winaver J; Hoffman A; Abassi ZA
    J Pharmacol Exp Ther; 2008 Aug; 326(2):414-22. PubMed ID: 18467593
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Improved kidney function with intravenous prostaglandin E1 in patients with terminal heart failure].
    Wutte M; Hülsmann M; Berger R; Rödler S; Frey B; Stanek B; Pacher R
    Wien Klin Wochenschr; 1998 Jul; 110(13-14):473-8. PubMed ID: 9746960
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The kidney in liver cirrhosis; clinical, functional and pathogenetic aspects].
    RUOL A; CORA D; DAL PALU C
    Acta Med Patav; 1957; 17(3):303-28. PubMed ID: 13544848
    [No Abstract]   [Full Text] [Related]  

  • 29. [Prostaglandins and renal function in patients with liver cirrhosis].
    Markov KhM; Markova MN
    Urol Nefrol (Mosk); 1982; (4):63-8. PubMed ID: 6753299
    [No Abstract]   [Full Text] [Related]  

  • 30. [Various aspects of water-salt metabolism in heart congestive failure].
    Condorelli M
    Atti Soc Ital Cardiol; 1966; 1():197-379. PubMed ID: 5988840
    [No Abstract]   [Full Text] [Related]  

  • 31. Vasopressin release, water channels, and vasopressin antagonism in cardiac failure, cirrhosis, and pregnancy.
    Schrier RW; Fassett RG; Ohara M; Martin PY
    Proc Assoc Am Physicians; 1998; 110(5):407-11. PubMed ID: 9756091
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Determination of the concentrating kidney function and renal acid excretion by clearance methods].
    Mertz DP
    Med Klin; 1966 Feb; 61(8):295-7. PubMed ID: 5982548
    [No Abstract]   [Full Text] [Related]  

  • 33. [Clinical use of bumetanide].
    Pellerito R; Bertola D; Soragna A
    Clin Ter; 1981 Sep; 98(6):651-60. PubMed ID: 7285545
    [No Abstract]   [Full Text] [Related]  

  • 34. [The stop-flow analysis of osmotic diuresis induced by sodium chloride].
    MAZZUOLI GF; FABBRINI A; CINOTTI GA; COEN G; BASCHIERI L
    Minerva Nefrol; 1962; 9():169-74. PubMed ID: 13934282
    [No Abstract]   [Full Text] [Related]  

  • 35. [Laboratory examinations in life insurance medicine].
    Wosegien F
    Lebensversicher Med; 1967 Jan; 19(1):7-11. PubMed ID: 4382855
    [No Abstract]   [Full Text] [Related]  

  • 36. [Some remarks on the test of induced diuresis].
    GOZARIU L; SAHLEANU V
    Z Gesamte Inn Med; 1962 May; 17():407-8. PubMed ID: 13900900
    [No Abstract]   [Full Text] [Related]  

  • 37. An explanation for and experimental correction of the abnormal water diuresis in cirrhosis.
    SCHEDL HP; BARTTER FC
    J Clin Invest; 1960 Feb; 39(2):248-61. PubMed ID: 14442514
    [No Abstract]   [Full Text] [Related]  

  • 38. [MODIFIED UROPOIESIS RELATED TO GASTRIC RESECTION].
    LIBSON IL
    Khirurgiia (Mosk); 1964 Aug; 40():70-7. PubMed ID: 14241871
    [No Abstract]   [Full Text] [Related]  

  • 39. [The pathological rhythm of diuresis after overloading with water in the diabetic].
    STOSIC L
    Nutr Dieta Eur Rev Nutr Diet; 1960; 2():47-52. PubMed ID: 13835004
    [No Abstract]   [Full Text] [Related]  

  • 40. Improving renal function during diuresis: useful information or just noise?
    Turner JM; Cox ZL; Testani JM
    Eur J Heart Fail; 2021 Jul; 23(7):1131-1133. PubMed ID: 34117684
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.